Close

FDA Approves Farxiga as Treatment for Type 2 Diabetes (BMY) (AZN)

January 8, 2014 11:49 AM EST Send to a Friend
The U.S. Food and Drug Administration approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login